RA Capital

Sparrow flying from a tree branch
Biotech

Sparrow flits forward with $95M for midstage diabetes asset

The Oregon biotech will use the raise for a phase 2b trial of oral small molecule clofutriben in patients with Type 2 diabetes and excess cortisol.
Darren Incorvaia Sep 24, 2025 11:22am
layoffs cut staff reduction workforce

Layoffs hit RA Capital's biotech incubator: Stat

May 14, 2025 12:54pm
A sleek metallic pen tip creates a trail of pink and purple glitter blending technology with artistic expression

Stylus outlines next-gen gene editing mission with $85M in hand

May 13, 2025 7:00am
shingles vaccine vaccination checklist

Curevo clinches $110M, nabs Moncef Slaoui to lead board

Mar 17, 2025 10:44am
red and purple piggy banks

Boston biotech banks $90M for next-gen bispecifics

Feb 14, 2025 10:10am
money flying in

ADC biotech adds on $135M series B

Nov 25, 2024 7:00am